# Clinical Study of AK159 in Healthy Postmenopausal Women

> **NCT01551602** · PHASE1 · COMPLETED · sponsor: **Asahi Kasei Therapeutics Corporation** · enrollment: 132 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** AK159
- **DRUG:** MN-10-T
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01551602
- **Lead sponsor:** Asahi Kasei Therapeutics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-09
- **Final completion:** 2012-10
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2016-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01551602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01551602, "Clinical Study of AK159 in Healthy Postmenopausal Women". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01551602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*